seri
nsubstitut
benzenesulfonamid
deriv
synthes
evalu
vitro
antimicrobi
antivir
cytotox
activ
antimicrobi
result
indic
compound
found
effect
one
gener
synthes
compound
bacteriostat
fungistat
action
cytotox
screen
result
indic
compound
less
activ
standard
drug
none
compound
inhibit
viral
replic
subtox
concentr
gener
presenc
pyrimidin
ring
electron
releas
group
orthoand
parasubstitut
benzoyl
moieti
favor
antimicrobi
activ
result
qsar
studi
demonstr
import
topolog
paramet
valenc
zero
order
molecular
connect
index
v
v
valenc
first
order
molecular
connect
index
v
v
describ
antimicrobi
activ
synthes
compound
product
host
elsevi
bv
behalf
king
saud
univers
grow
incid
microbi
resist
current
use
antibiot
repres
seriou
medic
problem
therefor
urgent
need
develop
new
class
therapeut
agent
treat
microbi
infect
combin
therapeut
drug
differ
mechan
action
one
method
adopt
treat
disord
mention
besid
exploit
new
target
anoth
approach
merg
two
pharmacophor
singl
molecul
approach
also
reduc
unwant
side
effect
success
hybrid
approach
alreadi
appli
develop
novel
antibacteri
antimalari
agent
overcom
drug
resist
solomon
et
al
cancer
becom
second
caus
mortal
world
develop
potent
specif
anticanc
agent
urgent
need
problem
like
sever
toxic
well
resist
exist
drug
kamal
et
al
human
immunodefici
viru
hiv
epidem
continu
enorm
human
health
consequ
around
five
million
adult
children
becam
infect
hiv
end
year
estim
million
peopl
worldwid
live
hivaid
nonnucleosid
revers
transcriptas
inhibitor
nnrti
gain
definit
place
treatment
infect
make
less
like
interfer
normal
function
dna
polymeras
therefor
less
toxic
treatment
hivinfect
patient
respect
isatin
betathiosemicarbazon
deriv
found
demonstr
rang
antivir
activ
bal
et
al
isatin
natur
product
found
number
plant
possess
antibacteri
karthikeyan
et
al
antifung
nandakumar
et
al
anticonvuls
sridhar
et
al
antiinflammatori
matheu
et
al
antihiv
bal
et
al
anticanc
sabet
et
al
activ
particular
methisazon
clinic
use
antivir
agent
thu
isatin
biolog
valid
start
point
design
synthesi
chemic
librari
direct
target
adibi
et
al
quantit
structureact
relationship
qsar
methodolog
use
correl
biolog
properti
molecul
molecular
descriptor
deriv
chemic
structur
mathemat
model
statist
valid
correl
chemic
structur
activ
profil
kumar
et
al
prompt
fact
continu
effort
develop
novel
compound
treatment
antimicrobi
anticanc
antivir
infect
narang
et
al
judg
et
al
herebi
report
synthesi
antimicrobi
cytotox
antivir
evalu
qsar
studi
nsubstitut
benzen
sulfonamid
synthesi
nsubstitut
benzenesulfonamid
accomplish
scheme
physicochem
characterist
synthes
compound
present
tabl
synthes
compound
character
ir
h
nmr
spectroscopi
result
accord
assign
molecular
structur
ir
stretch
band
rang
cm
str
confirm
acyl
isatin
ir
stretch
band
cm
str
confirm
format
schiff
base
peak
nh
plane
bend
cm
str
cm
confirm
presenc
sulfonamid
moieti
synthes
compound
h
nmr
spectra
signal
respect
proton
synthes
compound
confirm
base
chemic
shift
multipl
coupl
constant
spectra
show
singlet
ppm
correspond
nh
proton
multiplet
ppm
correspond
aromat
proton
specif
compound
show
singlet
ppm
correspond
ch
proton
isoxazol
ring
similarli
compound
show
singlet
ppm
correspond
coch
proton
compound
show
singlet
ppm
correspond
pyrimidineoch
proton
compound
show
singlet
ppm
correspond
pyridazineoch
proton
antimicrobi
activ
synthes
compound
determin
tube
dilut
method
cappucino
sherman
result
given
tabl
case
antimicrobi
activ
staphylococcu
aureu
found
activ
pmic
sa
emerg
potenti
candid
bacillu
subtili
escherichia
coli
candida
albican
pmic
valu
aspergillu
niger
emerg
effect
antifung
agent
pmican
gener
synthes
compound
bacteriostat
fungistat
minimum
bactericidalfungicid
concentr
mfcmbc
valu
higher
mic
valu
drug
consid
bacteriostaticfungistat
mfc
mbc
valu
higher
mic
valu
emami
et
al
cytotox
activ
synthes
isatin
deriv
determin
breast
cancer
mcf
colon
cancer
cell
line
use
tetrazolium
bromid
mtt
assay
mosmann
result
present
tabl
gener
synthes
compound
less
activ
compar
standard
drug
among
synthes
compound
n
benzenesulfonamid
n
benzenesulfonamid
effect
compound
mcf
cancer
cell
line
ic
lgml
respect
may
taken
lead
compound
develop
novel
cytotox
agent
antivir
activ
synthes
isatin
deriv
determin
differ
dna
rna
virus
none
deriv
found
markedli
activ
felin
corona
viru
felin
herp
viru
crfk
cell
cultur
herp
simplex
ko
herp
simplex
g
vaccinia
viru
vesicular
stomat
viru
herp
simplex
tkko
acv
r
hel
cell
cultur
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
hela
cell
cultur
coxsacki
viru
viru
sindbi
viru
punta
toro
viru
vero
cell
cultur
antihiv
activ
synthes
deriv
studi
wildtyp
iiib
rod
strain
cell
cultur
use
bromid
mtt
method
antihiv
screen
result
clearli
indic
none
synthes
compound
exhibit
signific
antihiv
activ
subtox
concentr
compound
show
margin
anticoxsacki
viru
activ
lg
ml
vero
hela
cell
cultur
high
antibacterialantifung
activ
compound
indic
presenc
electron
donat
methyl
group
pyrimidin
ring
increas
antimicrobi
activ
synthes
isatin
deriv
role
electron
releas
group
enhanc
antimicrobi
activ
isatin
deriv
pyrimidin
support
studi
pandeya
et
al
b
presenc
orthoand
para
chlorosubstitut
benzoyl
moieti
increas
antimicrobi
activ
synthes
isatin
deriv
wherea
unsubstitut
benzoyl
moieti
lead
decreas
biolog
activ
indic
presenc
chloro
group
ortho
para
posit
benzoyl
moieti
may
use
bind
receptor
role
electron
withdraw
group
improv
antibacteri
activ
support
studi
konda
et
al
c
cytotox
activ
result
indic
presenc
electron
releas
group
methyl
may
increas
cytotox
potenti
synthes
isatin
deriv
role
electron
releas
group
improv
cytotox
activ
support
studi
yogeeswari
et
al
mologni
et
al
scheme
scheme
synthesi
nsubstitut
benzenesulfonamid
find
summar
fig
qsar
studi
develop
multitarget
qsar
model
order
identifi
substitu
effect
antimicrobi
activ
establish
quantit
structureact
relationship
qsar
vitro
antimicrobi
activ
descriptor
code
lipophil
electron
steric
topolog
properti
molecul
consider
use
linear
free
energi
relationship
model
lfer
describ
hansch
fujita
antimicrobi
activ
data
determin
mic
valu
first
transform
pmic
valu
use
depend
variabl
qsar
studi
differ
molecular
descriptor
independ
variabl
like
log
octanolwat
partit
coeffici
log
p
molar
refract
mr
kier
molecular
connect
v
v
v
v
v
v
v
v
v
shape
ja
topolog
indic
randic
topolog
index
r
balaban
topolog
index
j
wiener
topolog
index
w
total
energi
te
energi
highest
occupi
molecular
orbit
homo
lowest
unoccupi
molecular
orbit
lumo
dipol
moment
l
electron
energi
ele
calcul
synthes
compound
present
tabl
hansch
fujita
hansch
et
al
kier
hall
randic
randic
balaban
wiener
accord
otqsar
model
one
use
five
differ
equat
differ
error
predict
activ
new
compound
five
microbi
speci
otqsar
model
present
whole
literatur
becom
impract
use
predict
compound
result
one
target
howev
recent
interest
increas
develop
multitarget
qsar
mtqsar
model
sigroha
et
al
sharma
et
al
kumar
et
al
opposit
otqsar
mtqsar
model
singl
equat
consid
natur
molecular
descriptor
common
essenti
describ
antibacteri
antifung
activ
base
fact
mention
continu
research
field
mtqsar
sigroha
et
al
sharma
et
al
kumar
et
al
attempt
develop
three
differ
type
mtqsar
model
viz
mtqsar
model
describ
antibacteri
activ
synthes
compound
aureu
b
subtili
e
coli
mtqsar
model
describ
antifung
activ
synthes
compound
c
albican
niger
well
common
mtqsar
model
describ
antimicrobi
overal
antibacteri
antifung
activ
isatin
deriv
mention
microorgan
order
develop
mtqsar
model
initi
calcul
averag
antibacteri
activ
antifung
activ
antimicrobi
activ
valu
substitut
isatin
deriv
tabl
present
studi
train
set
consist
isatin
deriv
use
linear
regress
model
gener
test
set
consist
isatin
deriv
use
cross
valid
gener
model
preliminari
analysi
carri
term
correl
analysi
correl
matrix
construct
antibacteri
activ
present
tabl
correl
differ
molecular
descriptor
antibacteri
antifung
activ
present
tabl
regress
model
develop
use
differ
molecular
descriptor
report
eq
togeth
statist
paramet
regress
antibacteri
activ
synthes
isatin
deriv
explain
topolog
paramet
valenc
zero
order
molecular
connect
index
v
v
eq
mtqsar
model
antibacteri
activ
thereaft
n
number
data
point
r
correl
coeffici
q
cross
valid
r
obtain
leav
one
method
standard
error
estim
f
fischer
statist
coeffici
v
v
eq
posit
antibacteri
activ
increas
increas
valu
v
v
clearli
evid
tabl
compound
highest
v
v
valu
highest
antibacteri
activ
valu
tabl
respect
similarli
compound
low
v
v
valu
minimum
antibacteri
activ
valu
eq
mean
predict
varianc
antibacteri
activ
topolog
indic
eg
v
v
numer
quantifi
molecular
topolog
sensit
bond
pattern
symmetri
content
heteroatom
well
degre
complex
atom
neighborhood
sinc
structur
compound
depend
connect
constitu
atom
topolog
descriptor
deriv
inform
base
upon
connect
reveal
role
structur
substructur
inform
molecul
estim
biolog
activ
viz
antimicrobi
activ
lather
madan
qsar
model
express
eq
cross
valid
high
valu
obtain
leav
one
loo
method
valu
greater
basic
requir
qualifi
qsar
model
valid
golbraikh
tropsha
predict
eq
evidenc
low
residu
valu
observ
tabl
well
plot
predict
pmic
ab
observ
pmic
ab
fig
plot
observ
pmic
ab
versu
residu
pmic
ab
fig
indic
system
error
develop
linear
regress
model
propag
residu
observ
side
zero
heravi
kyani
eq
develop
predict
antimicrobi
activ
isatin
deriv
antimicrobi
activ
synthes
isatin
deriv
govern
topolog
paramet
valenc
first
order
molecular
connect
index
v
v
eq
true
predict
power
qsar
model
test
abil
predict
accur
biolog
activ
compound
extern
test
set
compound
use
model
develop
low
residu
activ
valu
observ
case
test
set
justifi
select
multipl
linear
regress
model
express
eq
import
mention
statist
signific
correl
observ
case
antifung
activ
tabl
crossvalid
model
develop
antimicrobi
activ
eq
also
done
leav
one
loo
techniqu
schaper
case
eq
q
valu
less
develop
model
consid
invalid
one
forget
recommend
golbraikh
tropsha
recent
report
way
estim
true
predict
power
model
test
abil
predict
accur
biolog
activ
compound
predict
abil
develop
model
evidenc
low
residu
valu
observ
tabl
mtqsar
model
antimicrobi
activ
coeffici
v
v
posit
show
antimicrobi
activ
increas
increas
valu
v
v
synthes
compound
clearli
seen
result
antimicrobi
activ
tabl
valu
v
v
present
tabl
gener
qsar
studi
biolog
activ
compound
span
order
magnitud
present
studi
rang
antibacteri
antifung
activ
synthes
compound
within
one
order
figur
structureact
relationship
antimicrobi
activ
synthes
isatin
deriv
synthesi
antimicrobi
anticanc
antivir
evalu
qsar
studi
magnitud
import
note
predict
qsar
model
develop
present
studi
evidenc
low
residu
valu
accord
result
suggest
earlier
studi
bajaj
et
al
accord
reliabl
qsar
model
lie
predict
abil
even
though
activ
data
narrow
rang
recent
literatur
reveal
qsar
appli
describ
relationship
narrow
rang
biolog
activ
physicochem
properti
molecul
sharma
et
al
kumar
et
al
biolog
activ
data
lie
narrow
rang
presenc
minimum
standard
deviat
biolog
activ
justifi
use
qsar
studi
kumar
et
al
minimum
standard
deviat
tabl
observ
antimicrobi
activ
data
justifi
use
qsar
studi
observ
mtqsar
model
eq
antibacteri
antimicrobi
activ
synthes
isatin
deriv
govern
topolog
paramet
valenc
zero
order
molecular
connect
indic
v
v
valenc
first
order
molecular
connect
indic
v
v
start
materi
obtain
commerci
sourc
use
without
purif
solvent
dri
standard
procedur
reaction
progress
observ
thin
layer
chromatographi
melt
point
determin
open
capillari
tube
sonar
melt
point
apparatu
uncorrect
h
nuclear
magnet
reson
h
nmr
spectra
determin
bruker
mhz
nmr
spectromet
appropri
deuter
solvent
express
part
per
million
ppm
downfield
tetramethylsilan
intern
n
benzenesulfonamid
mp
antimicrobi
activ
perform
gramposit
bacteria
aureu
b
subtili
gramneg
bacteria
e
coli
two
fungal
strain
c
albican
niger
use
tube
dilut
method
cappucino
sherman
dilut
test
standard
compound
prepar
doubl
strength
nutrient
broth
ip
bacteria
sabouraud
dextros
broth
ip
fungi
annon
sampl
incub
h
bacteria
h
niger
h
c
albican
result
record
term
minimum
inhibitori
concentr
mic
minimum
bactericid
concentr
mbc
fungicid
concentr
mfc
determin
subcultur
cultur
tube
remain
clear
mic
determin
fresh
medium
mbc
mfc
valu
repres
lowest
concentr
compound
produc
end
point
reduct
rodriguezarguel
et
al
antivir
assay
except
antihuman
immunodefici
viru
hiv
assay
base
inhibit
virusinduc
cytopath
hel
herp
simplex
viru
type
g
vaccinia
viru
vesicular
stomat
viru
vero
coxsacki
punta
toro
viru
hela
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
mdck
influenza
b
viru
crfk
felin
corona
viru
fipv
felin
herp
viru
cell
cultur
confluent
cell
cultur
microtit
plate
inocul
cell
cultur
inhibitori
ccid
viru
ccid
viru
dose
infect
cell
cultur
presenc
vari
concentr
lgml
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antihiv
activ
synthes
deriv
studi
wildtyp
iiib
rod
strain
cell
cultur
use
bromid
mtt
method
pauwel
et
al
briefli
viru
stock
titrat
cell
express
cell
cultur
infect
dose
ccid
cell
suspend
cultur
medium
cell
ml
infect
hiv
multipl
infect
immedi
viral
infect
cell
suspens
place
well
flatbottom
microtit
tray
contain
variou
concentr
test
compound
day
incub
number
viabl
cell
determin
use
mtt
method
compound
test
parallel
cytotox
effect
uninfect
cell
cultur
cytotox
activ
synthes
compound
determin
breast
cancer
mcf
colon
cancer
cell
line
cancer
cell
line
purchas
american
type
cultur
collect
atcc
manassa
va
usa
cell
line
cultur
rpmi
sigma
supplement
heat
inactiv
fetal
bovin
serum
fb
paa
laboratori
penicillinstreptomycin
paa
laboratori
cultur
maintain
humidifi
incub
atmospher
cytotox
synthes
compound
variou
concentr
assess
use
tetrazolium
bromid
mtt
sigma
assay
describ
mosmann
mosmann
minor
modif
follow
h
incub
assay
plate
read
use
spectrophotomet
nm
data
gener
use
plot
doserespons
curv
concentr
test
compound
requir
kill
cell
popul
ic
determin
anticanc
activ
express
mean
ic
three
independ
experi
qsar
studi
use
find
correl
antimicrobi
activ
physicochem
paramet
synthes
isatin
deriv
structur
synthes
isatin
deriv
first
preoptim
molecular
mechan
forc
field
mm
procedur
includ
hyperchem
result
geometri
refin
mean
semiempir
method
parametr
chose
gradient
norm
limit
geometri
optim
lowest
energi
structur
use
molecul
calcul
physicochem
properti
use
tsar
softwar
window
tsar
version
furthermor
regress
analysi
perform
use
spss
softwar
packag
spss
window
predict
power
equat
valid
determin
crossvalid
r
q
use
leav
one
loo
crossvalid
method
schaper
statist
qualiti
equat
judg
paramet
like
correl
coeffici
r
standard
error
estim
varianc
ratio
f
specifi
degre
freedom
paramet
employ
confirm
predict
robust
develop
model
seri
nsubstitut
benzenesulfonamid
deriv
synthes
evalu
vitro
antimicrobi
antivir
cytotox
activ
antimicrobi
studi
result
indic
compound
n
benzenesulfonamid
n
benzenesulfonamid
found
effect
antimicrobi
agent
cytotox
screen
result
indic
synthes
compound
less
activ
standard
drug
antivir
screen
result
indic
none
synthes
compound
markedli
inhibit
viral
replic
subtox
concentr
gener
presenc
pyrimidin
ring
electron
releas
group
orthoand
parasubstitut
benzoyl
moieti
favor
antimicrobi
activ
result
qsar
studi
demonstr
import
topolog
paramet
valenc
zero
order
molecular
connect
index
v
v
valenc
first
order
molecular
connect
index
v
v
describ
antimicrobi
activ
